Видео ютуба по тегу Dmmr

The emerging role of ctDNA as a predicative marker in dMMR/MSI-H colorectal cancer
The emerging role of ctDNA as a predicative marker in dMMR/MSI-H colorectal cancer
Implications of phase III trials in endometrial cancer: dMMR patients and immunotherapy
Implications of phase III trials in endometrial cancer: dMMR patients and immunotherapy
Expert report on immune checkpoint inhibitors for dMMR Colorectal Cancer
Expert report on immune checkpoint inhibitors for dMMR Colorectal Cancer
IOU Youtube: Linking MSI-H/dMMR to IO research
IOU Youtube: Linking MSI-H/dMMR to IO research
#ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study
#ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study
Dr. Cercek on Chemotherapy Resistance in dMMR Rectal Cancer
Dr. Cercek on Chemotherapy Resistance in dMMR Rectal Cancer
Dr. Overman Discusses Nivolumab in Patients With dMMR/MSI H mCRC
Dr. Overman Discusses Nivolumab in Patients With dMMR/MSI H mCRC
Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC
Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC
Oncology - MOA of PD-1 Blockade in dMMR/MSI-H Tumors.
Oncology - MOA of PD-1 Blockade in dMMR/MSI-H Tumors.
Dr. Powell on MSI and dMMR as Potential Biomarkers in Endometrial Cancer
Dr. Powell on MSI and dMMR as Potential Biomarkers in Endometrial Cancer
CheckMate 8HW: Nivolumab Plus Ipilimumab for MSI-H/dMMR Metastatic Colorectal Cancer
CheckMate 8HW: Nivolumab Plus Ipilimumab for MSI-H/dMMR Metastatic Colorectal Cancer
What is microsatellite instability or MSI?
What is microsatellite instability or MSI?
Should You Buy A DMR? DMR basics and setup.
Should You Buy A DMR? DMR basics and setup.
Advancing neoadjuvant immunotherapy in dMMR deficient colon cancer
Advancing neoadjuvant immunotherapy in dMMR deficient colon cancer
Dr. Nelson on the CheckMate-142 Trial in MSI-H/dMMR mCRC
Dr. Nelson on the CheckMate-142 Trial in MSI-H/dMMR mCRC
CheckMate 8HW: nivolumab and ipilimumab in MSI-H/dMMR mCRC
CheckMate 8HW: nivolumab and ipilimumab in MSI-H/dMMR mCRC
A New DMR Hotspot for 2024
A New DMR Hotspot for 2024